Resources

The George Institute Researchers Find Diabetes Increases the Risk of Heart Failure for Women at a Higher Rate

A global study of 12 million people has found diabetes increases the risk of heart failure and this increase is greater for women than men.  Researchers from The George Institute for Global Health determined that this differential was greater in Type 1 than Type 2 diabetes. Type 1 diabetes is associated with a 47% excess […]

了解更多

2019年7月19日

Award Highlights 乔治临床( George Clinical ) as Leading Employer in Asia-Pacific Region

Last year 乔治临床( George Clinical ) gained recognition by the Mandatory Provident Fund (MPF) legislation for their provision of good MPF benefits in Hong Kong.  The Mandatory Provident Fund Sche […]

了解更多

2019年7月13日

乔治临床( George Clinical ) Welcomes FDA Framework for Real World Evidence Program

December of 2018 saw the FDA release their “Framework For Evaluating the Potential Use of Real-World Evidence (RWE)” to support the approval of a new indication for a drug already approved und […]

了解更多

2019年6月1日

CTTI Recommendations Developed to Improve Engagement in Mobile Clinical Trials

乔治临床( George Clinical ) is proud to have been involved in developing the recently announced recommendations by the Clinical Trial Transformation Initiative (CTTI): The Recommendations for Enga […]

了解更多

2019年6月1日

乔治临床( George Clinical ) Expands Asia-Pacific Footprint with New Location in the Philippines

SYDNEY, May 29, 2019 – 乔治临床( George Clinical ), a global scientifically-backed clinical research organization (CRO), has again expanded its extensive Asia-Pacific footprint through the opening […]

了解更多

2019年5月29日

乔治临床( George Clinical ) Awarded Taiwanese Drug License

 SYDNEY, May 15, 2019 – 乔治临床( George Clinical ), a global scientifically-backed clinical research organization (CRO), has significantly expanded its capabilities in Taiwan having been granted  […]

了解更多

2019年5月14日

EPS International and 乔治临床( George Clinical ) Form Strategic Partnership for the Asia-Pacific Region

Sydney, Australia, April 24, 2019 – EPS International Holdings Co., Ltd. (HQ: Tokyo, Japan; Representative Director and President: Hisashi Tanaka; “EPSI” hereafter) and 乔治临床( Georg […]

了解更多

2019年4月24日

乔治临床( George Clinical ) Client Noxopharm Announces Chemotherapy Enhancement Program Expansion

Noxopharm, a clinical-stage Australian drug development company currently working with 乔治临床( George Clinical ), is seeking to establish Veyonda®, an innovative dosage formulation of the experi […]

了解更多

2019年4月20日

乔治临床( George Clinical ) Scientific Leader Named Chief Medical Officer of OneOncology

OneOncology, a national partnership of community oncologists, recently announced that Lee Schwartzberg, MD, FACP, a member of the 乔治临床( George Clinical ) scientific leadership committee, has b […]

了解更多

2019年4月17日

Late Breaking Clinical Trial CREDENCE Webcast to Stream this Month

ISN World Congress of Nephrology will be live streaming “Late Breaking Clinical Trials” from WCN 2019. The purpose of the webcast is to give the worldwide nephrology community in-depth underst […]

了解更多

2019年4月5日

Join Our Mailing List

required
required
required
required
I wish to subscribe to George Clinical communications.
required

在您的网络中添加 乔治临床( George Clinical )